EA200400813A1 - Белок, имеющий в своей структуре цистиновые узлы - Google Patents

Белок, имеющий в своей структуре цистиновые узлы

Info

Publication number
EA200400813A1
EA200400813A1 EA200400813A EA200400813A EA200400813A1 EA 200400813 A1 EA200400813 A1 EA 200400813A1 EA 200400813 A EA200400813 A EA 200400813A EA 200400813 A EA200400813 A EA 200400813A EA 200400813 A1 EA200400813 A1 EA 200400813A1
Authority
EA
Eurasian Patent Office
Prior art keywords
nodes
protein
cystic
proteins
insp002
Prior art date
Application number
EA200400813A
Other languages
English (en)
Other versions
EA007611B1 (ru
Inventor
Марк Дуглас Дйвис
Кристофер Бенджамин Фелпс
Ричард Джозеф Фэйган
Кристин Пауэр
Мелани Йорк
Марк Ибберсон
Original Assignee
Арес Трейдинг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арес Трейдинг С.А. filed Critical Арес Трейдинг С.А.
Publication of EA200400813A1 publication Critical patent/EA200400813A1/ru
Publication of EA007611B1 publication Critical patent/EA007611B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)

Abstract

Настоящее изобретение относится к новому белку INSP002, идентифицированному в настоящей заявке как секретируемый белок, то есть как член семейства DAN, относящегося к суперсемейству цитокинов, имеющих в своей структуре цистиновые узлы, и к применению этого белка и последовательностей нуклеиновой кислоты кодирующих генов для диагностики, профилактики и лечения заболеваний.Отчет о международном поиске был опубликован 2003.08.28.
EA200400813A 2001-12-21 2002-12-20 Белок, имеющий в своей структуре цистиновые узлы EA007611B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0130738.8A GB0130738D0 (en) 2001-12-21 2001-12-21 Protein
PCT/GB2002/005865 WO2003055911A2 (en) 2001-12-21 2002-12-20 Cystine-knot fold protein

Publications (2)

Publication Number Publication Date
EA200400813A1 true EA200400813A1 (ru) 2005-04-28
EA007611B1 EA007611B1 (ru) 2006-12-29

Family

ID=9928236

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400813A EA007611B1 (ru) 2001-12-21 2002-12-20 Белок, имеющий в своей структуре цистиновые узлы

Country Status (15)

Country Link
US (1) US7619065B2 (ru)
EP (1) EP1463754B1 (ru)
JP (1) JP2005528336A (ru)
KR (1) KR20040089093A (ru)
CN (1) CN1620466A (ru)
AT (1) ATE397624T1 (ru)
AU (1) AU2002353207B2 (ru)
CA (1) CA2470781A1 (ru)
DE (1) DE60227002D1 (ru)
EA (1) EA007611B1 (ru)
ES (1) ES2306802T3 (ru)
GB (1) GB0130738D0 (ru)
IL (2) IL162592A0 (ru)
MX (1) MXPA04006062A (ru)
WO (1) WO2003055911A2 (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130738D0 (en) 2001-12-21 2002-02-06 Serono Internat S A Protein
US7193069B2 (en) 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA
US9045553B2 (en) * 2004-05-27 2015-06-02 Acceleron Pharma, Inc. Cerberus/Coco derivatives and uses thereof
US20100183695A1 (en) 2004-05-27 2010-07-22 John Knopf Cerberus/coco derivatives and uses thereof
CA2657683A1 (en) * 2006-01-12 2007-07-19 Mark Douglas Davies Cystine-knot fold cytokine
EP2099471A2 (en) 2006-12-08 2009-09-16 Acceleron Pharma, Inc. Uses of cerberus, coco and derivatives thereof
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
AU2010211428B2 (en) 2009-02-03 2015-09-03 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells.
TWI799366B (zh) 2015-09-15 2023-04-21 美商建南德克公司 胱胺酸結骨架平臺
WO2018115879A1 (en) 2016-12-21 2018-06-28 Mereo Biopharma 3 Limited Use of anti-sclerostin antibodies in the treatment of osteogenesis imperfecta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130738D0 (en) 2001-12-21 2002-02-06 Serono Internat S A Protein
US7193069B2 (en) * 2002-03-22 2007-03-20 Research Association For Biotechnology Full-length cDNA

Also Published As

Publication number Publication date
MXPA04006062A (es) 2004-09-27
AU2002353207B2 (en) 2009-01-08
WO2003055911A2 (en) 2003-07-10
EA007611B1 (ru) 2006-12-29
DE60227002D1 (en) 2008-07-17
EP1463754B1 (en) 2008-06-04
GB0130738D0 (en) 2002-02-06
CA2470781A1 (en) 2003-07-10
JP2005528336A (ja) 2005-09-22
AU2002353207A1 (en) 2003-07-15
EP1463754A2 (en) 2004-10-06
KR20040089093A (ko) 2004-10-20
US20050186663A1 (en) 2005-08-25
CN1620466A (zh) 2005-05-25
IL162592A0 (en) 2005-11-20
IL162592A (en) 2009-12-24
US7619065B2 (en) 2009-11-17
ATE397624T1 (de) 2008-06-15
ES2306802T3 (es) 2008-11-16
WO2003055911A3 (en) 2003-08-28
WO2003055911A8 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
EA200400813A1 (ru) Белок, имеющий в своей структуре цистиновые узлы
EA199900355A1 (ru) Теломераза обратная тринскриптаза
AR008588A1 (es) Molecula de acido nucleico aislada que hibridiza con un gen de saliva de pulga, proteina aislada codificada por dicha molecula, composicion terapeuticapara tratar la dermatitis alergica, kit de ensayo para determinar dicha dermatitis, molecula, virus y celula recombinantes, y anticuerpo aislado
EA200400812A1 (ru) Секретируемый белок
NO20052956D0 (no) Defensinprotiner
EA200501711A1 (ru) Семейство секретируемых белков
ATE395602T1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
NO20053575L (no) Metallprotease proteiner
MX9805158A (es) Adn que codifica una proteina activadora de plasminogeno.
NO20052525L (no) Spleisevariant av humant hypofyseveksthormon
MXPA05009954A (es) Familia de proteinas secretadas.
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2004053117A3 (en) Serine protease
EA200501843A1 (ru) Tnf-подобный секретируемый белок
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
ATE438660T1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
WO2003054178A3 (en) Metalloprotease proteins
WO2002062845A3 (en) Adhesion molecules
WO2002062976A3 (en) Serine proteases
WO2002044382A8 (en) Cytokine-like proteins
WO2002029062A3 (en) Cytokine proteins

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU